219 related articles for article (PubMed ID: 11179023)
1. Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma).
Aradhya S; Courtois G; Rajkovic A; Lewis RA; Levy M; Israël A; Nelson DL
Am J Hum Genet; 2001 Mar; 68(3):765-71. PubMed ID: 11179023
[TBL] [Abstract][Full Text] [Related]
2. A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations.
Aradhya S; Woffendin H; Jakins T; Bardaro T; Esposito T; Smahi A; Shaw C; Levy M; Munnich A; D'Urso M; Lewis RA; Kenwrick S; Nelson DL
Hum Mol Genet; 2001 Sep; 10(19):2171-9. PubMed ID: 11590134
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation.
Fusco F; Bardaro T; Fimiani G; Mercadante V; Miano MG; Falco G; Israël A; Courtois G; D'Urso M; Ursini MV
Hum Mol Genet; 2004 Aug; 13(16):1763-73. PubMed ID: 15229184
[TBL] [Abstract][Full Text] [Related]
4. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO).
Zonana J; Elder ME; Schneider LC; Orlow SJ; Moss C; Golabi M; Shapira SK; Farndon PA; Wara DW; Emmal SA; Ferguson BM
Am J Hum Genet; 2000 Dec; 67(6):1555-62. PubMed ID: 11047757
[TBL] [Abstract][Full Text] [Related]
5. Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-κB activation and leads to incontinentia pigmenti.
Bal E; Laplantine E; Hamel Y; Dubosclard V; Boisson B; Pescatore A; Picard C; Hadj-Rabia S; Royer G; Steffann J; Bonnefont JP; Ursini VM; Vabres P; Munnich A; Casanova JL; Bodemer C; Weil R; Agou F; Smahi A
J Allergy Clin Immunol; 2017 Dec; 140(6):1671-1682.e2. PubMed ID: 28249776
[TBL] [Abstract][Full Text] [Related]
6. NEMO gene mutations in Chinese patients with incontinentia pigmenti.
Hsiao PF; Lin SP; Chiang SS; Wu YH; Chen HC; Lin YC
J Formos Med Assoc; 2010 Mar; 109(3):192-200. PubMed ID: 20434027
[TBL] [Abstract][Full Text] [Related]
7. [NEMO Delta 4-10 deletion of NEMO gene in Chinese incontinentia pigmenti cases].
Li L; Song GW; DU JB; Liu JR; Xu FS; Liu XY; Zhang T
Zhonghua Er Ke Za Zhi; 2005 Feb; 43(2):89-92. PubMed ID: 15833158
[TBL] [Abstract][Full Text] [Related]
8. Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome.
Kenwrick S; Woffendin H; Jakins T; Shuttleworth SG; Mayer E; Greenhalgh L; Whittaker J; Rugolotto S; Bardaro T; Esposito T; D'Urso M; Soli F; Turco A; Smahi A; Hamel-Teillac D; Lyonnet S; Bonnefont JP; Munnich A; Aradhya S; Kashork CD; Shaffer LG; Nelson DL; Levy M; Lewis RA;
Am J Hum Genet; 2001 Dec; 69(6):1210-7. PubMed ID: 11673821
[TBL] [Abstract][Full Text] [Related]
9. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.
Smahi A; Courtois G; Vabres P; Yamaoka S; Heuertz S; Munnich A; Israël A; Heiss NS; Klauck SM; Kioschis P; Wiemann S; Poustka A; Esposito T; Bardaro T; Gianfrancesco F; Ciccodicola A; D'Urso M; Woffendin H; Jakins T; Donnai D; Stewart H; Kenwrick SJ; Aradhya S; Yamagata T; Levy M; Lewis RA; Nelson DL
Nature; 2000 May; 405(6785):466-72. PubMed ID: 10839543
[TBL] [Abstract][Full Text] [Related]
10. Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes.
Aradhya S; Bardaro T; Galgóczy P; Yamagata T; Esposito T; Patlan H; Ciccodicola A; Munnich A; Kenwrick S; Platzer M; D'Urso M; Nelson DL
Hum Mol Genet; 2001 Oct; 10(22):2557-67. PubMed ID: 11709543
[TBL] [Abstract][Full Text] [Related]
11. Incontinentia pigmenti (Bloch-Sulzberger syndrome).
Narayanan MJ; Rangasamy S; Narayanan V
Handb Clin Neurol; 2015; 132():271-80. PubMed ID: 26564087
[TBL] [Abstract][Full Text] [Related]
12. Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease.
Conte MI; Pescatore A; Paciolla M; Esposito E; Miano MG; Lioi MB; McAleer MA; Giardino G; Pignata C; Irvine AD; Scheuerle AE; Royer G; Hadj-Rabia S; Bodemer C; Bonnefont JP; Munnich A; Smahi A; Steffann J; Fusco F; Ursini MV
Hum Mutat; 2014 Feb; 35(2):165-77. PubMed ID: 24339369
[TBL] [Abstract][Full Text] [Related]
13. Immunodeficiency in Two Female Patients with Incontinentia Pigmenti with Heterozygous NEMO Mutation Diagnosed by LPS Unresponsiveness.
Ohnishi H; Kishimoto Y; Taguchi T; Kawamoto N; Nakama M; Kawai T; Nakayama M; Ohara O; Orii K; Fukao T
J Clin Immunol; 2017 Aug; 37(6):529-538. PubMed ID: 28702714
[TBL] [Abstract][Full Text] [Related]
14. [An incontinentia pigmenti family with deletion in both NEMO gene and pseudogene DeltaNEMO].
Zhang G; Shi H; Du X; Shao M; Zhou Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):573-5. PubMed ID: 18841575
[TBL] [Abstract][Full Text] [Related]
15. NEMO gene rearrangement (exon 4-10 deletion) and genotype-phenotype relationship in Japanese patients with incontinentia pigmenti and review of published work in Japanese patients.
Okita M; Nakanishi G; Fujimoto N; Shiomi M; Yamada T; Wataya-Kaneda M; Takijiri C; Yokoyama Y; Sunohara A; Tanaka T
J Dermatol; 2013 Apr; 40(4):272-6. PubMed ID: 23398170
[TBL] [Abstract][Full Text] [Related]
16. A new mutation in exon 7 of NEMO gene: late skewed X-chromosome inactivation in an incontinentia pigmenti female patient with immunodeficiency.
Martinez-Pomar N; Munoz-Saa I; Heine-Suner D; Martin A; Smahi A; Matamoros N
Hum Genet; 2005 Dec; 118(3-4):458-65. PubMed ID: 16228229
[TBL] [Abstract][Full Text] [Related]
17. Two cases of misinterpretation of molecular results in incontinentia pigmenti, and a PCR-based method to discriminate NEMO/IKKgamma dene deletion.
Bardaro T; Falco G; Sparago A; Mercadante V; Gean Molins E; Tarantino E; Ursini MV; D'Urso M
Hum Mutat; 2003 Jan; 21(1):8-11. PubMed ID: 12497627
[TBL] [Abstract][Full Text] [Related]
18. The common NF-κB essential modulator (NEMO) gene rearrangement in Korean patients with incontinentia pigmenti.
Song MJ; Chae JH; Park EA; Ki CS
J Korean Med Sci; 2010 Oct; 25(10):1513-7. PubMed ID: 20890435
[TBL] [Abstract][Full Text] [Related]
19. A case of incontinentia pigmenti in Japan and its genetic examination.
Huang J; Kondo H; Uchio E
Jpn J Ophthalmol; 2007; 51(2):142-5. PubMed ID: 17401626
[TBL] [Abstract][Full Text] [Related]
20. Microdeletion/duplication at the Xq28 IP locus causes a de novo IKBKG/NEMO/IKKgamma exon4_10 deletion in families with Incontinentia Pigmenti.
Fusco F; Paciolla M; Pescatore A; Lioi MB; Ayuso C; Faravelli F; Gentile M; Zollino M; D'Urso M; Miano MG; Ursini MV
Hum Mutat; 2009 Sep; 30(9):1284-91. PubMed ID: 19603533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
